Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

NCT04494386 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19
Corona Virus Infection
SARS-CoV Infection
ARDS
Coronavirus

Interventions

BIOLOGICAL: Umbilical Cord Lining Stem Cells (ULSC)
OTHER: Placebo (carrier control)

Sponsor

Restem, LLC.